False Positive results may be obtained with the identified lots when using a negative patient sample or a negative control.
Source facts
Action
A Device Recall Letter was sent to customers that received the affected product lots on 6/11/04 via Federal Express Priority. The accounts were informed of the false positive readings, and were requested to destroy any affected inventory of the recalled lots.
Initiated
2004-06-11
Root cause
Other
Terminated
2004-10-05
Distribution
The product was not distributed in the U.S. The product was distributed internationally through Abbott affiliates in Argentina, Korea, the United kingdom, Japan, Singapore, the Dominican Republic, Canada, Hong Kong, Chile and Germany
Recall number
Z-1048-04
Recall status
Terminated
CDRH record ID
33584
FDA classified
2004-07-20
Recall event number
29352
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.